| Download ( PDF | 1MB) |
Expression of class I major histocompatibility complex antigens in Epstein-Barr virus-carrying lymphoblastoid cell lines and Burkitt lymphoma cells
Article
Jilg, W., Voltz, R., Markert-Hahn, C., Mairhofer, H., Münz, I. and Wolf, Hans J. (1991) Expression of class I major histocompatibility complex antigens in Epstein-Barr virus-carrying lymphoblastoid cell lines and Burkitt lymphoma cells. Cancer research 51 (1), pp. 27-32.DOI to cite this document: 10.5283/epub.20469
Abstract
Epstein-Barr virus (EBV) carrying lymphoblastoid cell lines (LCLs) and EBV-positive Burkitt lymphoma (BL) cells were compared for their expression of class I antigens of the major histocompatibility complex. Five common BL lines, LCLs, pokeweed mitogen-stimulated blasts and resting B-cells from healthy donors, and eight pairs of BL cells and LCLs, each pair originating from one patient, were ...
Epstein-Barr virus (EBV) carrying lymphoblastoid cell lines (LCLs) and EBV-positive Burkitt lymphoma (BL) cells were compared for their expression of class I antigens of the major histocompatibility complex. Five common BL lines, LCLs, pokeweed mitogen-stimulated blasts and resting B-cells from healthy donors, and eight pairs of BL cells and LCLs, each pair originating from one patient, were tested. Quantitative analysis was performed using a radioimmunoassay; qualitative aspects were studied by one- and two-dimensional gel electrophoresis. In general, LCLs expressed significantly higher amounts of class I antigens than BL cells, the latter showing class I densities similar to or lower than peripheral resting B-cells. From analysis of the expression of class I-specific RNA, there is some evidence that class I antigen expression is regulated on the transcriptional level. In two BL cells studied, class I expression could be enhanced by gamma-interferon, whereas the corresponding LCLs seemed to be refractory to this treatment. One- and two-dimensional gel electrophoresis showed that in some BL lines, in addition to the generally lower class I expression, distinct class I specificities were down-regulated. None of these alterations in class I expression was EBV specific; however, they may well play a role in the recognition of BL cells and LCLs by cellular immune mechanisms. Thus, down-regulation of class I antigens may contribute to the resistance of BL cells to cytotoxic T-lymphocytes, whereas their enhanced expression may improve the recognition of EBV-infected LCLs.
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||||||||||||||||||||||||||||||
| Journal or Publication Title | Cancer research | ||||||||||||||||||||||||||||||||
| Publisher | American Association for Cancer Research : AACR | ||||||||||||||||||||||||||||||||
| Volume | 51 | ||||||||||||||||||||||||||||||||
| Number of Issue or Book Chapter | 1 | ||||||||||||||||||||||||||||||||
| Page Range | pp. 27-32 | ||||||||||||||||||||||||||||||||
| Date | 1991 | ||||||||||||||||||||||||||||||||
| Date of publication | 13 Apr 2011 09:09 | ||||||||||||||||||||||||||||||||
| Institutions | Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene | ||||||||||||||||||||||||||||||||
| Identification Number |
| ||||||||||||||||||||||||||||||||
| Classification |
| ||||||||||||||||||||||||||||||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||||||||||||||||||||||||||||||
| Status | Published | ||||||||||||||||||||||||||||||||
| Refereed | Unknown | ||||||||||||||||||||||||||||||||
| Created at the University of Regensburg | Unknown | ||||||||||||||||||||||||||||||||
| URN of the UB Regensburg | urn:nbn:de:bvb:355-epub-204694 | ||||||||||||||||||||||||||||||||
| Item ID | 20469 |
Download Statistics
Download Statistics